AXGN

#2056
Axogen, Inc. Common Stock
34.4600 USD
+2.96%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
34.4600
34.4600
Jahresspanne
17.1400
35.9999
Tagesänderung
+2.96%
Monatliche Änderung
+5.03%
6 month change
+88.93%
Jahresänderung
+88.93%
Vorheriger Schlusskurs
33.4700
Eröffnung
34.4600
Bid
Ask
Tief
34.4600
High
34.4600
Volumen
111
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Dividenden
Vierteljährlich Jährlich
  • Market Capitalization 1.7884 B
  • Employee 622
  • Founded 2002
  • CEO N/A
  • Website www.axogeninc.com
  • Headquarter Minnesota, United States
  • FIGI BBG000BN46R9
  • Industry Technology
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
-96.26
Preis-Umsatz-Verhältnis
6.69

Axogen Inc

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator. As of 2019, Axogen was the only commercially available allograft approved by the Food and Drug Administration for clinical use.

Nachrichten